Siemens Unveils MR Oncology Applications and Dedicated Breast ... International Business Times, NY - Nov 30, 2008 With prostate cancer as the second leading cause of cancerdeath in American men, MR plays a vital role in determining which men are atserious risk. ...
Raised hopes for prostate cancer sufferers Times Online, UK - These injections have allowed thousands of men with advanced prostatic cancer, or a constitution too frail for radical surgery, to continue to live a ...
UPI NewsTrack Health and Science News United Press International - Nov 28, 2008 The device also is seen by some doctors as an important advancement in the fight against prostate cancer, the No. 2 cancer killer of men. ...
Hot Docs: Did Bush White House 'Airbrush' Iraq War History ... U.S. News & World Report, DC - Much of the decline is due to progress against several particularly common types of cancer: lung, breast, colorectal, and prostate cancer cases have shown ...
UI seeks men for prostate study Iowa City Press Citizen, IA - Nov 30, 2008 Men with a history of prostate surgery or a history of cancer, except for successfully treated skin cancer, are not eligible to participate. ...
Source: Google News
Recent News and Articles on the Keywords: prostate cancer + cancer + prostate Related to the article below (Last Update: 8/7/2008)
Brachytherapy Vs. Cryoablation In The Treatment Of Prostate Cancer Medical News Today (press release), UK - Cohen JK, Miller RJ, Ahmed S, Lotz MJ, Baust J Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary ...
Delay in body growth linked to prostate cancer Reuters - Aug 5, 2008 NEW YORK (Reuters Health) - Boys who reach their adult body size in their early 20s may be more prone to prostate cancer later in life than their peers who ...
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study. - JM Chan, MJ Stampfer, E Giovannucci, PH Gann, J Ma … - The Journal of Urology, 1998 - jurology.com ... Plasma Insulin-Like Growth Factor-I and ProstateCancer Risk: A Prospective Study. ...
Citing Articles TOP. Obesity and prostatecancer. Current Opinion in Urology. ...
Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer - E Giovannucci, A Ascherio, EB Rimm, MJ Stampfer, … - jnci, 1995 - jnci.oxfordjournals.org ... Intake of Carotenoids and Retino in Relation to Risk of ProstateCancer. ... No consistent
association was observed for dietary retinol and risk of prostatecancer. ...
The Influence of Finasteride on the Development of Prostate Cancer - IM Thompson, PJ Goodman, CM Tangen, MS Lucia, GJ … - New England Journal of Medicine, 2003 - content.nejm.org The Influence of Finasteride on the Development of ProstateCancer. Ian M. Thompson,
MD, Phyllis J. Goodman, MS, Catherine M. Tangen, Dr.PH, M. Scott Lucia, MD ...
Quality-of-life outcomes in men treated for localized prostate cancer - MS Litwin, RD Hays, A Fink, PA Ganz, B Leake, GE … - JAMA, 1995 - Am Med Assoc ... Quality-of-life outcomes in men treated for localized prostatecancer. ... ABSTRACT |
FULL TEXT. Natural History of Early, Localized ProstateCancer Johansson et al. ...
Nearly 1.5 million American men over age 75 get PSA tests each year to screen for prostate cancer, according to a study published in the Journal of the National Cancer Institute (Vol. 95, No. 23:1792-1797). Unfortunately, there's little proof that the screenings do them any good.
Because prostate cancer typically grows so slowly, elderly men are more likely to die from other causes (heart disease, for instance) before prostate cancer can even cause symptoms, much less kill them. Furthermore, if prostate cancer is detected in these men, the treatment for it can cause serious side effects like incontinence and impotence that can lower a man's quality of life without necessarily increasing his quantity of life.
For those reasons, wrote lead author Grace Lu-Yao, PhD, of the New Jersey Cancer Institute, "There has been general agreement that elderly men (i.e., those aged 75 years or older) should not be screened."
Every Man Is Different
Some health organizations do not recommend PSA (or prostate-specific antigen) tests for men of any age. The American Cancer Society (ACS) recommends that screening be offered, after a discussion of the pros and cons, to men who have a life expectancy of at least 10 years.
"Not every 75-year-old man is the same," said Durado Brooks, MD, director of prostate and colorectal cancer for ACS. The decision to be screened needs to be based on each man's individual health, he explained.
Lu-Yao and her colleagues wanted to get a better idea of how many elderly men were getting screened, whether doctors were recommending the test, and whether the men were being told of the drawbacks and benefits before being tested.
Many Doctors Recommending Testing
Elderly men without prostate cancer were asked whether they had been given a blood test for PSA in the previous year. Elevated PSA levels could be a sign of prostate cancer, although other less worrisome conditions also can raise PSA; a biopsy is usually needed to make a firm diagnosis.
More than 32% of men over age 75 reported having had a PSA test in the previous 12 months. Of those, more than 88% said their doctor had first recommended the test.
"It is somewhat surprising that so many physicians would suggest screening (or be perceived as suggesting screening) in elderly men when the benefits have not even been established among younger men," the researchers wrote.
Screening men who are unlikely to benefit from the test results may not be the best use of health care dollars, they said. And elderly men who are diagnosed as having prostate cancer may experience substantial anxiety if they choose not to treat it immediately (a strategy known as "expectant therapy").
Factors that raise prostate cancer risk, such as race and family history of the disease, did not appear to influence the screening rates; neither did a man's overall health.
Two-Thirds Discussed Risks, Benefits
More than 66% of the elderly men who were screened reported having a discussion with their doctor about the advantages and disadvantages of the PSA test.
Although that number is still too low ? all men should have this discussion before choosing to be screened ? it's higher than previously believed, Brooks said. This study could prompt more men to ask their doctors about whether prostate cancer screening is right for them, he added.
The researchers say screening decisions need to be made by patients, doctors, and society working together. They urge the development of better strategies to increase understanding of the risks and benefits of PSA testing in elderly men.